V. L. Tallec

Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study

D. Visvikis, C. Rest, J. Metges, 2008, Nuclear medicine communications.

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer.

O. Bouché, A. Bedjaoui, F. Retornaz, 2018, European journal of cancer.

Use of Positron Emission Tomography in Surgery Follow-Up of Esophageal Cancer

D. Visvikis, C. Rest, J. Bail, 2009, Journal of Gastrointestinal Surgery.